Under Pressure

Update Item Information
Identifier walsh_2015_s1_c5-1
Title Under Pressure
Creator Nathan H. Kung, Collin M. McClelland, Gregory P. Van Stavern, MD, Associate Professor, Ophthalmology & Visual Sciences and Neurology, Washington University School of Medicine
Subject Paraneoplastic Disorders, Polyneuropathy, Papilledema, Optic Nerve Sheath Fenestration
History A 29-year-old woman was referred to neuro-ophthalmology clinic for 1 year of headaches and papilledema discovered 2 months earlier. She complained of recently blurred vision but no positional headache, pulsatile tinnitus, transient visual obscurations, or other neurologic issues. She used no medications and denied any recent illnesses except for thrombocythemia (591k) on recent blood work, and had no significant past medical history. Her initial examination in 4/2009 revealed normal acuity with 20/20 VA OU, equal pupils without RAPD, and severe grade 4 papilledema OU with several choroidal folds through both maculae. No hemorrhages were noted. All other portions of the examination were normal. Her BMI was 27. Humphrey SITA Standard visual fields were performed and showed slight enlargement of the blind spot OU with a nasal step in the L eye. An MRI of the brain and orbits with and without gadolinium was normal with normal venous flow voids. CSF analysis showed an opening pressure of 26 cm H2O with 1 RBC, 1 WBC, Protein 75, Glucose 69, and no abnormalities on cytology. Although she had atypical features, a preliminary diagnosis of Probable Pseudotumor Cerebri was made and she was initiated on acetazolamide, with improved papilledema over the next several months. Over the next three years, however, she developed worsening vision with multiple additional symptoms.
Disease/Diagnosis POEMS syndrome. She fulfilled all major criteria: 1) lambda-restricted plasma cell population, 2) polyneuropathy, 3) sclerotic bone lesion, 4) Castleman disease; and all minor criteria: 1) organomegaly (splenomegaly), extravascular volume overload (body wall anasarca), 3) endocrinopathy (elevated TSH/ACTH/Prolactin), 4) skin changes (hyperpigmented rash), 5) papilledema, and 6) thrombocytosis.
Date 2015-02
References 1. Dispenzieri A. POEMS Syndrome: 2014 Update on Diagnosis, Risk-Stratification, and Management. Am J Hematol. 89:214-223, 2014. 2. Dispenzieri A. How I Treat POEMS Syndrome. Blood. 119(24):5650-5658, 2012. 3. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar V, Therneau TM. POEMS Syndrome: Definitions and Long-Term Outcome. Blood. 101:2496-2506, 2003. 4. Kaushik M, Pulido JS, Abreu R, Amselem L, Dispenzieri A. Ocular Findings in Patients with Polyneuropathy, Organomegaly, and Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome. Ophthalmology. 118:778-782, 2011. 5. Latov N. Diagnosis and Treatment of Chronic Acquired Demyelinating Polyneuropathies. Nat Rev Neurol. 10:435-446, 2014.
Language eng
Format video/mp4
Type Image/MovingImage
Source 47th Annual Frank Walsh Society Meeting
Relation is Part of NANOS Annual Meeting Frank B. Walsh Sessions: 2015
Collection Neuro-Ophthalmology Virtual Education Library - Walsh Session Annual Meeting Archives https://novel.utah.edu/Walsh/index3.html
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah, 10 N 1900 E SLC, UT 84112-6231
Rights Management Copyright 2015. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6448j2p
Setname ehsl_novel_fbw
ID 179274
Reference URL https://collections.lib.utah.edu/ark:/87278/s6448j2p
Back to Search Results